S&P 500   3,370.70 (-0.08%)
DOW   27,909.58 (+0.05%)
QQQ   271.54 (-0.34%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
S&P 500   3,370.70 (-0.08%)
DOW   27,909.58 (+0.05%)
QQQ   271.54 (-0.34%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
S&P 500   3,370.70 (-0.08%)
DOW   27,909.58 (+0.05%)
QQQ   271.54 (-0.34%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
S&P 500   3,370.70 (-0.08%)
DOW   27,909.58 (+0.05%)
QQQ   271.54 (-0.34%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
Log in

NASDAQ:CLVSClovis Oncology SEC Filings & 10K Form

$4.82
-0.07 (-1.43 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.76
Now: $4.82
$4.92
50-Day Range
$4.90
MA: $6.33
$7.47
52-Week Range
$2.93
Now: $4.82
$17.37
Volume91,910 shs
Average Volume6.68 million shs
Market Capitalization$425.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.4

SEC Filings

Clovis Oncology (NASDAQ:CLVS) SEC Filings

DateFilerForm TypeView
08/06/2020
4:14 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2020
4:01 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:00 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:00 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:00 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
10:05 AM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/23/2020
4:16 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2020
4:15 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:31 PM
Clovis Oncology (Issuer)
GRAHAM GINGER L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:30 PM
Clovis Oncology (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:57 PM
Clovis Oncology (Issuer)
McKinley Edward J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:55 PM
Azelby Robert (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:54 PM
Clovis Oncology (Issuer)
KLINGENSTEIN PAUL H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:53 PM
Clovis Oncology (Issuer)
SPICKSCHEN THORLEF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:51 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:50 PM
BLAIR JAMES C (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
3:49 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
3:36 PM
Clovis Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/28/2020
6:41 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:27 PM
Clovis Oncology (Filer)
Form 424B5
05/06/2020
2:12 PM
Clovis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2020
3:38 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2020
2:25 PM
Clovis Oncology (Filer)
Form DEFA14A
04/24/2020
2:22 PM
Clovis Oncology (Filer)
Form DEF 14A
04/16/2020
4:30 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
4:22 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
3:44 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:42 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
4:28 PM
Clovis Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2020
4:22 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
6:27 PM
Clovis Oncology (Issuer)
MAHAFFY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:25 PM
Clovis Oncology (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
02/14/2020
11:00 AM
Clovis Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2020
9:54 AM
Clovis Oncology (Subject)
WHITEBOX ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2020
8:25 AM
Camber Capital Management LP (Filed by)
Clovis Oncology (Subject)
Form SC 13G/A
02/13/2020
3:20 PM
Clovis Oncology (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/13/2020
7:26 AM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/12/2020
10:00 AM
Clovis Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2020
9:36 AM
Clovis Oncology (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/10/2020
6:32 AM
BlackRock Inc. (Filed by)
Clovis Oncology (Subject)
Form SC 13G/A
02/06/2020
3:19 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
5:50 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
5:48 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
5:47 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2020
5:45 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
10:15 AM
Clovis Oncology (Subject)
Elk Creek Partners, LLC (Filed by)
Form SC 13G/A
01/08/2020
4:15 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
8:12 AM
Clovis Oncology (Filer)
Form 424B5
01/07/2020
7:20 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2019
11:15 PM
Clovis Oncology (Filer)
Form EFFECT
12/26/2019
3:16 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:15 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
11:40 AM
Clovis Oncology (Filer)
Form S-3/A
12/05/2019
3:06 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:06 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:05 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:05 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
4:13 PM
Clovis Oncology (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
11/29/2019
3:05 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
1:28 PM
Clovis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
7:01 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
3:13 PM
Clovis Oncology (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
09/24/2019
3:46 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
3:45 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
11:15 PM
Clovis Oncology (Filer)
Form EFFECT
09/10/2019
2:50 PM
Clovis Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
09/06/2019
3:45 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
3:45 PM
Clovis Oncology (Issuer)
Gross Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
3:45 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
3:45 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:30 PM
Clovis Oncology (Filer)
Form POS AM
08/28/2019
3:15 PM
Clovis Oncology (Issuer)
MUEHL DANIEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
3:37 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
3:15 PM
ATWOOD BRIAN G (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
8:49 PM
BLAIR JAMES C (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
1:39 PM
Clovis Oncology (Subject)
Elk Creek Partners, LLC (Filed by)
Form SC 13G
08/19/2019
3:49 PM
Clovis Oncology (Subject)
WHITEBOX ADVISORS LLC (Filed by)
Form SC 13G
08/19/2019
3:06 PM
Clovis Oncology (Subject)
D. E. SHAW & CO, L.P. (Filed by)
Form SC 13G
08/19/2019
7:35 AM
Clovis Oncology (Issuer)
MAHAFFY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
4:45 PM
Clovis Oncology (Issuer)
SPICKSCHEN THORLEF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
8:30 AM
CITADEL ADVISORS LLC (Filed by)
Clovis Oncology (Subject)
Form SC 13G
08/15/2019
3:12 PM
Clovis Oncology (Issuer)
SPICKSCHEN THORLEF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:29 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
11:09 AM
Clovis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
7:10 AM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
3:24 PM
Clovis Oncology (Issuer)
KLINGENSTEIN PAUL H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
11:15 PM
Clovis Oncology (Filer)
Form EFFECT
07/10/2019
8:38 AM
Clovis Oncology (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
07/02/2019
8:14 AM
Clovis Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/01/2019
4:29 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
3:45 PM
Clovis Oncology (Issuer)
Rolfe Lindsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:45 PM
Clovis Oncology (Issuer)
IVERS-READ GILLIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
7:24 PM
Clovis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
3:30 PM
Clovis Oncology (Filer)
Form 8-K/A
06/10/2019
3:46 PM
BLAIR JAMES C (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:47 PM
Clovis Oncology (Issuer)
SPICKSCHEN THORLEF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:46 PM
Azelby Robert (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:46 PM
ATWOOD BRIAN G (Reporting)
Clovis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:46 PM
Clovis Oncology (Issuer)
KLINGENSTEIN PAUL H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:45 PM
Clovis Oncology (Issuer)
Fair Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.